Global Lung Cancer Therapeutics Market Assessment, By Disease Type [Non-small Cell Lung Cancer, Small Cell Lung Cancer], By Treatment [Chemotherapy, Radiation Therapy, Immunotherapy Targeted Therapy, Others], By Drugs Class [Immunosuppressant, Monoclonal Antibodies, Tyrosine Kinase, Epidermal Growth Factors Receptors, Topoisomerase Inhibitors, Others], By Route of Administration [Oral, Injectable], By Distribution Channel [Hospital, Specialty Clinics, Clinical Research Institutes, Home Care Settings, Ambulatory Surgical Centers], By Region, Opportunities and Forecast, 2016-2030F